Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Acumen Pharmaceuticals, Inc.”

6 pharma patents match "Acumen Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Acumen Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Acumen Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9320793

    Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42

    Acumen Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  2. US 9217024

    ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

    Acumen Pharmaceuticals, Inc. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  3. US 9006283

    Methods of modifying amyloid β oligomers using non-peptidic compounds

    Acumen Pharmaceuticals, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  4. US 8962677

    Methods of restoring cognitive ability using non-peptidic compounds

    Acumen Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  5. US 8507206

    Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)

    Acumen Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  6. US 7964359

    Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance

    Acumen Pharmaceuticals, Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.